Search by Drug Name or NDC

    NDC 00135-0578-01 FLONASE 325; 2; 5 mg/1; mg/1; mg/1 Details

    FLONASE 325; 2; 5 mg/1; mg/1; mg/1

    FLONASE is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00135-0578
    Product ID 0135-0578_0a4a4e6d-9f4f-d55b-e063-6394a90ab7eb
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name FLONASE
    Proprietary Name Suffix Headache and Allergy Relief
    Non-Proprietary Name acetaminophen, chlorpheniramine maleate, phenylephrine hcl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 325; 2; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 00135-0578-01 (00135057801)

    NDC Package Code 0135-0578-01
    Billing NDC 00135057801
    Package 1 BLISTER PACK in 1 CARTON (0135-0578-01) / 12 TABLET in 1 BLISTER PACK
    Marketing Start Date 2022-03-10
    NDC Exclude Flag N
    Pricing Information N/A